Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of the PD‐1/PD‐L1 Signaling in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Recent Insights and Future Directions
Yan Mi, Jinming Han, Jie Zhu, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 12, pp. 6249-6271
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway
Ming Xiang, Tingting Liu, Cheng Tian, et al.
Pharmacological Research (2022) Vol. 177, pp. 106092-106092
Open Access | Times Cited: 55
Beyond Cancer: Regulation and Function of PD-L1 in Health and Immune-Related Diseases
Amke C. Beenen, Tatjana Sauerer, Niels Schaft, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8599-8599
Open Access | Times Cited: 24
Crosstalk between dendritic cells and regulatory T cells: Protective effect and therapeutic potential in multiple sclerosis
Ruoyu Li, Hui Li, Xiaoyan Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Revealing the role of regulatory b cells in cancer: development, function and treatment significance
Ruyu Ye, Sijia Li, Yuxiao Li, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access
Natural killer cells in multiple sclerosis: foe or friends?
Fatemeh Aghaee, Mohammadreza Abedinpour, Saeid Anvari, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
Myeloid checkpoints for cancer immunotherapy
Yixin Qian, Ting Yang, Huan Liang, et al.
Chinese Journal of Cancer Research (2022) Vol. 34, Iss. 5, pp. 460-482
Open Access | Times Cited: 18
Extracellular Vesicle-Based Therapeutics in Neurological Disorders
Yiwen Yuan, Jian Sun, Tongyao You, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2652-2652
Open Access | Times Cited: 17
Adaptive and Innate Immunity Are Key Drivers of Age at Onset of Multiple Sclerosis
Elina Misicka, Yunfeng Huang, Stephanie Loomis, et al.
Neurology Genetics (2024) Vol. 10, Iss. 3
Open Access | Times Cited: 3
Structure of PD1 and its mechanism in the treatment of autoimmune diseases
Mahdi Rezayi, Arezoo Hosseini
Cell Biochemistry and Function (2023) Vol. 41, Iss. 7, pp. 726-737
Open Access | Times Cited: 9
Reduced Expression of PD-1 in Circulating CD4+ and CD8+ Tregs Is an Early Feature of RRMS
Maja Machcińska, Magdalena Kierasińska, Martyna Michniowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3185-3185
Open Access | Times Cited: 10
Novel immunoprofiling method for diagnosing SLE and evaluating therapeutic response
Jan‐Mou Lee, Ming‐Huang Chen, Kai-Yuan Chou, et al.
Lupus Science & Medicine (2022) Vol. 9, Iss. 1, pp. e000693-e000693
Open Access | Times Cited: 10
The α5-nAChR/PD-L1 axis facilitates lung adenocarcinoma cell migration and invasion
Ping Zhu, Guiyu Kang, Yang Jiao, et al.
Human Cell (2022) Vol. 35, Iss. 4, pp. 1207-1218
Closed Access | Times Cited: 9
The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis
Maria Sofia Basile, Placido Bramanti, Emanuela Mazzon
Genes (2022) Vol. 13, Iss. 8, pp. 1319-1319
Open Access | Times Cited: 9
The clinical association of programmed death-1/PD-L1 axis, myeloid derived suppressor cells subsets and regulatory T cells in peripheral blood of stable COPD patients
Mingqiang Zhang, Yinghua Wan, Jie Han, et al.
PeerJ (2024) Vol. 12, pp. e16988-e16988
Open Access | Times Cited: 1
Enhanced Therapeutic Effects of Human Mesenchymal stem Cells Transduced with Secreted Klotho in a Murine Experimental Autoimmune Encephalomyelitis Model
Narges Maleki, Maryam Rezapour Kalkhoran, Mohammad Sajad Emami Aleagha, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10381-10397
Closed Access | Times Cited: 1
Neurotropic murine coronavirus mediated demyelination: Factors dampening pathogenesis
Mi‐Hyun Hwang, Cornelia C. Bergmann
Journal of Neuroimmunology (2024) Vol. 393, pp. 578382-578382
Closed Access | Times Cited: 1
PD1+CD4+ T cells promote receptor editing and suppress autoreactivity of CD19+CD21low B cells within the lower respiratory airways in adenovirus pneumonia
Bingtai Lu, Yanfang Zhang, Jun Wang, et al.
Mucosal Immunology (2024) Vol. 17, Iss. 5, pp. 1045-1059
Open Access | Times Cited: 1
Peptide-directed interference of PD-1/PD-L1 binding increases B lymphocyte function after infectious bursal disease viral infection
Qiuyu Zhang, Guo-Peng Sun, Yue Feng, et al.
Poultry Science (2024) Vol. 103, Iss. 12, pp. 104389-104389
Open Access | Times Cited: 1
Unraveling the Immunopathogenesis of Multiple Sclerosis: The Dynamic Dance of Plasmablasts and Pathogenic T Cells
Yasunari Matsuzaka, Ryu Yashiro
Biologics (2023) Vol. 3, Iss. 3, pp. 232-252
Open Access | Times Cited: 2
αPD-1 immunotherapy promotes IL-17A production and promotes the formation of acute radiation-induced lung injury
Shilong Liu, Lili Liu, Jianli Ma, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 6, pp. 2881-2893
Open Access
Amelioration of experimental autoimmune encephalomyelitis by exogenous soluble PD-L1 is associated with restraining dendritic cell maturation and CCR7-mediated migration
Yan Mi, Jianjun Dong, Caiyun Liu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113398-113398
Open Access
Forsythiaside A prevents zymosan A-induced cell migration in neutrophil-differentiated HL-60 cells via PD-1/PD-L1 pathway
Xinyu Zhang, Aiyun Li, Yue Xu, et al.
Heliyon (2023) Vol. 9, Iss. 2, pp. e13490-e13490
Open Access | Times Cited: 1
Anemoside B4 ameliorates experimental autoimmune encephalomyelitis in mice by modulating inflammatory responses and the gut microbiota
Min Zou, Fangjun Chen, Li-rong Deng, et al.
European Journal of Pharmacology (2022) Vol. 931, pp. 175185-175185
Closed Access | Times Cited: 2
Structure of PD1 and its Mechanism in the Treatment of autoimmune diseases
Arezoo Hosseini, Mahdi Rezaei
Authorea (Authorea) (2023)
Open Access
Association of plasma sPD‐1 and sPD‐L1 with disease status and future relapse in AQP4‐IgG (+) NMOSD
Jia Liu, Xi Shao, Jingya Fan, et al.
Annals of Clinical and Translational Neurology (2023) Vol. 11, Iss. 2, pp. 436-449
Open Access
Page 1 - Next Page

Scroll to top